Poseida Therapeutics, Inc. (PSTX) Tops Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Preferred dividends: -142.41K
Today's EPS Names:
SUNB, CULP, KFY, More
Financial Fact:
Preferred dividends: -142.41K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q1 EPS of ($0.25), $0.17 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $28.14 million versus the consensus estimate of $10.03 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
- BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
